Two research lines

Actoprotectors

Soviet military and sports pharmacology in the Vinogradov / Kirov MMA tradition. Small molecules studied for physical work under stress and low oxygen.

What the line is

Actoprotector writing grew inside Soviet military and sports pharmacology associated with V. M. Vinogradov and the Kirov Military Medical Academy tradition in Leningrad. The programme treated work capacity, hypoxia, and heat or load stress as experimental endpoints. Animal series and military human literature used those endpoints as the measure of interest.

The molecules themselves are small compounds. Benzimidazoles such as bemitil sit on one scaffold. Adamantane derivatives such as bromantane sit on another. The shared experimental question was how physical work held up when oxygen was scarce or when heat and load stacked together. That question organised the shelf long before English secondary digests arrived.

Where it sat historically

Primary density lives in Soviet military and sports-pharmacology series from the mid-twentieth century onward. Institute house journals, academy collections, and later Russian sports-medicine papers keep most of that trail. English often carries a thin stub or a doping-control abstract that points at the older work without reproducing it.

Bromantane (Ladasten in Russia) later appears in sports-medicine and WADA-adjacent paper trails after the 1996 Atlanta positives. That doping-control layer is part of the public record this archive maps. It sits beside the Russian endurance and load-test literature. The older experimental trail remains the denser layer for pharmacology endpoints.

Ademol is a Ukrainian registration from the Institute of Organic Chemistry / Darnitsa work of the 1990s. It sits outside the classic Soviet military and space programmes. The compound was registered, later discontinued, and now appears here as a related small-molecule shelf item with a coherent cerebroprotective animal series. Ethomersol and chlodantane appear among the wider archive siblings on the same instrument sheet.

How papers talk about mechanism

Mechanism language in this line is framed by the papers themselves. For the benzimidazole side, bemitil is repeatedly placed with aminothiol antihypoxants. Mapped animal work clusters on traumatic brain injury and hypoxia adaptation, bronchopulmonary inflammation immunology, and lipid-peroxidation or antioxidant readouts under stress. Review writing treats metabolic and antihypoxic framing as the class vocabulary for that scaffold. Ethomersol, a 5-ethoxy bemitil analogue, inherits the same antihypoxic comparison language in derivative screens and hepatoregenerative series.

For the adamantane side, bromantane papers talk differently. Endurance and behavioural load tests sit next to immunomodulatory and cytokine work under the Ladasten name. Mechanism titles in the mapped set include gene-expression and histone-acetylation frames, plus neurotrophin and mitogen-activated kinase activation language. Older archive questions also place bromantane beside GABAergic and dopaminergic upregulation stories. Class reviews sometimes pull the compound into an adaptogen-adjacent neighbourhood. Those are literature frames. This page grades none of them as settled pharmacology.

Ademol’s densest trail is the Khodakovsky cerebroprotective series. Authors there propose NMDA-receptor modulation as a candidate basis for ischemia and trauma findings. The dossier records that as suggested mechanism language, correlational in the mapped set. Chlodantane appears mainly through sparse pharmacokinetic and class-review literature as a chlorobenzoyl analogue of bromantane, sometimes framed as a single-dose adaptogen of the oestrogen-activity type in pre-clinical writing.

Compounds on this shelf

Featured dossiers on this site: bemitil (benzimidazole reference; Metaprot / Bemaktor historically), bromantane (adamantane face; Ladasten), and ademol (Ukrainian adamantane branch; cerebroprotective series). Open those pages for the paper maps attached to each name.

Archive siblings on the same shelf include ethomersol (5-ethoxy bemitil analogue) and chlodantane (bromantane analogue). They carry thinner or noisier trails. They stay visible so the scaffold cloud around the featured three remains readable.

How to read this shelf here

Start from a featured dossier. Read the takeaways and the themed literature chapters before the paper lists. Russian full-text ranks first when CyberLeninka or institute PDFs are attached. PubMed rows are kept when they sit on the same trail; name-collision noise is trimmed where the dossiers already say so.

Use Papers for the CyberLeninka-led index across compounds, and Methodology for how the pipeline attaches records. Treat every page as an archive map. No dose, route, schedule, or medical advice appears on this shelf.

Bioregulators

St. Petersburg peptide school under V. Kh. Khavinson. Short peptides and tissue extracts studied as organ-targeted bioregulators.

What the line is

The bioregulator line is the St. Petersburg Institute of Bioregulation and Gerontology corpus associated with V. Kh. Khavinson, with earlier thymic work also tied to V. G. Morozov. The school studied short peptides and tissue extracts as organ-targeted bioregulators. Pineal, thymic, bronchial, and other tissue neighbourhoods each accumulated their own sequences and fractions.

What holds the shelf together is the institutional trail. Papers cluster in St. Petersburg school series and same-circle reviews. English secondary writing often arrives later and thinner. For a visitor who wants the literature as it was written, the Russian primary and the school’s own experimental programmes are the centre of gravity.

Two product forms in the literature

Two production forms coexist in the papers. Sequence-locked synthetics are chemically defined short peptides: epitalon (Ala-Glu-Asp-Gly, AEDG), thymogen (Glu-Trp, EW), vilon (Lys-Glu, KE), pinealon (Glu-Asp-Arg, EDR), chonluten (Glu-Asp-Gly, EDG), and related sequences. Each name points at a fixed amino-acid string.

Tissue fractions are the other form. Thymalin is the older Morozov-protocol calf-thymus polypeptide fraction: a mixture of sequences. School writing later attributes reported effects to ultrashort peptides inside that fraction; thymogen is one defined fragment sold separately. Epithalamin sits in the pineal neighbourhood as the polypeptide fraction from which epitalon was characterised, then made chemically. Keeping fraction and synthetic distinct matters when reading the dossiers.

Mechanism language in the school literature

Mechanism claims in the group literature often point to chromatin-level or transcription-factor-level interaction, and to tissue-specific peptide frames tied to the organ of origin. That is how the papers describe the work. This archive maps those frames. It does not convert them into efficacy grades.

Epitalon papers cluster around telomerase-adjacent cell and oocyte work, pineal / melatonin / circadian frames, and immune-endocrine restore after pinealectomy, with smaller ophthalmology and genotype-dependent antimutagenic series. Chonluten, the N-terminal tripeptide of epitalon, is studied mainly as a respiratory-tissue proliferotrope in organotypic culture; neighbouring work discusses bronchial-epithelium gene-expression readouts and histone-binding biophysics as adjacent mechanism context.

Thymogen papers describe TLR / RLR signalling frames in monocytes, trauma combinations with neutrophil readouts, aged-spleen apoptosis markers, and hematologic innate-immunity series. Vilon maps onto trauma and lipid-peroxidation / cytokine series, comparative surgical immunity papers beside thymalin, PBMC TNFα work, and cartilage explant culture. Pinealon carries a nootropic framing in Russian literature, with actoprotective, cognitive, and free-radical experimental threads across hypoxia and aging models. Thymalin’s trail stays closer to immune-cell and phagocytosis readouts, with additional animal series in behavioural and hepatic models. Across the shelf, gene-expression and chromatin language recurs as the school’s preferred mechanistic vocabulary.

Compounds on this shelf

Featured on this site: epitalon (pineal tetrapeptide AEDG), thymogen (Glu-Trp), thymalin (thymus polypeptide fraction), vilon (Lys-Glu), pinealon (Glu-Asp-Arg), and chonluten (Glu-Asp-Gly). Those six are the entry shelf for the bioregulator line.

Wider archive compounds include bronchogen, cortagen, epithalamin, livagen, cardiogen, crystagen, ovagen, pancragen, testagen, and related tissue-fraction or sequence neighbours. They stay on the map so the school’s organ-targeted vocabulary remains visible beyond the featured six.

How to read this shelf here

Open a featured dossier and stay with the St. Petersburg trail. Takeaways name the sequence or fraction first. Literature chapters stay inside papers already mapped to that compound. Russian full-text on CyberLeninka is the densest layer for most of this shelf; PubMed adds titles that sit in the same ecology.

Watch product-name neighbours. Pineamine titles in climacteric literature sit beside pinealon and are kept distinct on that dossier. Thymalin manufacturing disruption (Samson-Med) is recorded as archive fact on the thymalin page. Fraction versus synthetic, school series versus adjacent product literature: those distinctions are how the dossiers are built. Read them that way. Archive map only.